nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS2—glaucoma	0.387	1	CbGaD
Meloxicam—CYP2C9—Diclofenamide—glaucoma	0.0456	0.167	CbGbCtD
Meloxicam—CYP2C9—Dorzolamide—glaucoma	0.0441	0.162	CbGbCtD
Meloxicam—CYP2C9—Methazolamide—glaucoma	0.0393	0.144	CbGbCtD
Meloxicam—CYP3A4—Pilocarpine—glaucoma	0.0338	0.124	CbGbCtD
Meloxicam—CYP3A4—Brinzolamide—glaucoma	0.0265	0.0973	CbGbCtD
Meloxicam—CYP3A4—Dorzolamide—glaucoma	0.0256	0.094	CbGbCtD
Meloxicam—CYP3A4—Methazolamide—glaucoma	0.0228	0.0838	CbGbCtD
Meloxicam—CYP3A4—Acetazolamide—glaucoma	0.0183	0.067	CbGbCtD
Meloxicam—CYP3A4—Clonidine—glaucoma	0.0165	0.0606	CbGbCtD
Meloxicam—Lornoxicam—PTGS2—glaucoma	0.00153	0.409	CrCbGaD
Meloxicam—Tenoxicam—PTGS2—glaucoma	0.00137	0.365	CrCbGaD
Meloxicam—Piroxicam—PTGS2—glaucoma	0.000844	0.225	CrCbGaD
Meloxicam—PGD—Disease—LRP12—glaucoma	0.000326	0.00796	CbGpPWpGaD
Meloxicam—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000325	0.00793	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000318	0.00776	CbGpPWpGaD
Meloxicam—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000309	0.00753	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000302	0.00736	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TXN—glaucoma	0.000301	0.00734	CbGpPWpGaD
Meloxicam—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000299	0.00728	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—SLC6A1—glaucoma	0.000268	0.00655	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—SOD1—glaucoma	0.000268	0.00654	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000262	0.00639	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000261	0.00636	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000256	0.00623	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000253	0.00616	CbGpPWpGaD
Meloxicam—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000251	0.00611	CbGpPWpGaD
Meloxicam—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000245	0.00598	CbGpPWpGaD
Meloxicam—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000243	0.00592	CbGpPWpGaD
Meloxicam—ABCC4—Ectoderm Differentiation—PAX6—glaucoma	0.000232	0.00567	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000224	0.00546	CbGpPWpGaD
Meloxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000221	0.00539	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFB2—glaucoma	0.000219	0.00534	CbGpPWpGaD
Meloxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000217	0.00528	CbGpPWpGaD
Meloxicam—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000216	0.00528	CbGpPWpGaD
Meloxicam—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000214	0.00523	CbGpPWpGaD
Meloxicam—PGD—Disease—FGFR1OP—glaucoma	0.00021	0.00513	CbGpPWpGaD
Meloxicam—PGD—Disease—HEYL—glaucoma	0.00021	0.00513	CbGpPWpGaD
Meloxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.00021	0.00511	CbGpPWpGaD
Meloxicam—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000204	0.00497	CbGpPWpGaD
Meloxicam—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	0.0002	0.00487	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000197	0.00479	CbGpPWpGaD
Meloxicam—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000194	0.00473	CbGpPWpGaD
Meloxicam—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000189	0.0046	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—FN1—glaucoma	0.000187	0.00455	CbGpPWpGaD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000178	0.00434	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CA1—glaucoma	0.000176	0.00429	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000176	0.00429	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000175	0.00427	CbGpPWpGaD
Meloxicam—Decreased appetite—Pilocarpine—glaucoma	0.000174	0.000588	CcSEcCtD
Meloxicam—Feeling abnormal—Travoprost—glaucoma	0.000173	0.000587	CcSEcCtD
Meloxicam—Conjunctivitis—Timolol—glaucoma	0.000173	0.000585	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dorzolamide—glaucoma	0.000173	0.000585	CcSEcCtD
Meloxicam—Alopecia—Betaxolol—glaucoma	0.000173	0.000585	CcSEcCtD
Meloxicam—Palpitations—Clonidine—glaucoma	0.000173	0.000585	CcSEcCtD
Meloxicam—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000172	0.00421	CbGpPWpGaD
Meloxicam—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000172	0.000584	CcSEcCtD
Meloxicam—Gastrointestinal pain—Travoprost—glaucoma	0.000172	0.000583	CcSEcCtD
Meloxicam—Loss of consciousness—Clonidine—glaucoma	0.000172	0.000581	CcSEcCtD
Meloxicam—Feeling abnormal—Brinzolamide—glaucoma	0.000171	0.00058	CcSEcCtD
Meloxicam—Mental disorder—Betaxolol—glaucoma	0.000171	0.00058	CcSEcCtD
Meloxicam—Pain—Pilocarpine—glaucoma	0.000171	0.000578	CcSEcCtD
Meloxicam—Constipation—Pilocarpine—glaucoma	0.000171	0.000578	CcSEcCtD
Meloxicam—PGD—Metabolism—CTSA—glaucoma	0.000171	0.00416	CbGpPWpGaD
Meloxicam—Cough—Clonidine—glaucoma	0.00017	0.000577	CcSEcCtD
Meloxicam—Sweating—Timolol—glaucoma	0.00017	0.000577	CcSEcCtD
Meloxicam—Dizziness—Apraclonidine—glaucoma	0.00017	0.000577	CcSEcCtD
Meloxicam—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00017	0.00415	CbGpPWpGaD
Meloxicam—Malnutrition—Betaxolol—glaucoma	0.00017	0.000576	CcSEcCtD
Meloxicam—Erythema—Betaxolol—glaucoma	0.00017	0.000576	CcSEcCtD
Meloxicam—Urticaria—Dorzolamide—glaucoma	0.000168	0.000568	CcSEcCtD
Meloxicam—Body temperature increased—Dorzolamide—glaucoma	0.000167	0.000566	CcSEcCtD
Meloxicam—Abdominal pain—Dorzolamide—glaucoma	0.000167	0.000566	CcSEcCtD
Meloxicam—Tension—Betaxolol—glaucoma	0.000167	0.000565	CcSEcCtD
Meloxicam—Sinusitis—Timolol—glaucoma	0.000167	0.000565	CcSEcCtD
Meloxicam—Dysgeusia—Betaxolol—glaucoma	0.000167	0.000564	CcSEcCtD
Meloxicam—Arthralgia—Clonidine—glaucoma	0.000166	0.000563	CcSEcCtD
Meloxicam—Abdominal pain—Travoprost—glaucoma	0.000166	0.000563	CcSEcCtD
Meloxicam—Agranulocytosis—Timolol—glaucoma	0.000166	0.000562	CcSEcCtD
Meloxicam—Anxiety—Clonidine—glaucoma	0.000166	0.000561	CcSEcCtD
Meloxicam—Asthenia—Acetazolamide—glaucoma	0.000165	0.00056	CcSEcCtD
Meloxicam—Dizziness—Bimatoprost—glaucoma	0.000165	0.00056	CcSEcCtD
Meloxicam—Nervousness—Betaxolol—glaucoma	0.000165	0.000559	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000165	0.000559	CcSEcCtD
Meloxicam—Urticaria—Brinzolamide—glaucoma	0.000165	0.000559	CcSEcCtD
Meloxicam—Feeling abnormal—Pilocarpine—glaucoma	0.000165	0.000557	CcSEcCtD
Meloxicam—Discomfort—Clonidine—glaucoma	0.000164	0.000556	CcSEcCtD
Meloxicam—ABCC4—Fluoropyrimidine Activity—TP53—glaucoma	0.000164	0.004	CbGpPWpGaD
Meloxicam—Vomiting—Apraclonidine—glaucoma	0.000164	0.000555	CcSEcCtD
Meloxicam—Muscle spasms—Betaxolol—glaucoma	0.000164	0.000554	CcSEcCtD
Meloxicam—Gastrointestinal pain—Pilocarpine—glaucoma	0.000163	0.000553	CcSEcCtD
Meloxicam—Hypersensitivity—Brimonidine—glaucoma	0.000163	0.000552	CcSEcCtD
Meloxicam—Dry mouth—Clonidine—glaucoma	0.000163	0.000551	CcSEcCtD
Meloxicam—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000162	0.00396	CbGpPWpGaD
Meloxicam—Dermatitis—Apraclonidine—glaucoma	0.000162	0.00055	CcSEcCtD
Meloxicam—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000162	0.00395	CbGpPWpGaD
Meloxicam—Headache—Apraclonidine—glaucoma	0.000161	0.000547	CcSEcCtD
Meloxicam—PGD—Metabolism—CA2—glaucoma	0.000161	0.00393	CbGpPWpGaD
Meloxicam—Confusional state—Clonidine—glaucoma	0.000161	0.000544	CcSEcCtD
Meloxicam—Vision blurred—Betaxolol—glaucoma	0.00016	0.000543	CcSEcCtD
Meloxicam—Rhinitis—Timolol—glaucoma	0.00016	0.000542	CcSEcCtD
Meloxicam—Oedema—Clonidine—glaucoma	0.000159	0.00054	CcSEcCtD
Meloxicam—Tremor—Betaxolol—glaucoma	0.000159	0.00054	CcSEcCtD
Meloxicam—Asthenia—Brimonidine—glaucoma	0.000159	0.000538	CcSEcCtD
Meloxicam—Infection—Clonidine—glaucoma	0.000158	0.000536	CcSEcCtD
Meloxicam—Body temperature increased—Pilocarpine—glaucoma	0.000158	0.000534	CcSEcCtD
Meloxicam—Abdominal pain—Pilocarpine—glaucoma	0.000158	0.000534	CcSEcCtD
Meloxicam—Ill-defined disorder—Betaxolol—glaucoma	0.000158	0.000534	CcSEcCtD
Meloxicam—Diarrhoea—Acetazolamide—glaucoma	0.000158	0.000534	CcSEcCtD
Meloxicam—Rash—Bimatoprost—glaucoma	0.000158	0.000533	CcSEcCtD
Meloxicam—Dermatitis—Bimatoprost—glaucoma	0.000157	0.000533	CcSEcCtD
Meloxicam—Oedema peripheral—Timolol—glaucoma	0.000157	0.000532	CcSEcCtD
Meloxicam—Anaemia—Betaxolol—glaucoma	0.000157	0.000532	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000157	0.00383	CbGpPWpGaD
Meloxicam—Shock—Clonidine—glaucoma	0.000157	0.000531	CcSEcCtD
Meloxicam—Connective tissue disorder—Timolol—glaucoma	0.000157	0.000531	CcSEcCtD
Meloxicam—Pruritus—Brimonidine—glaucoma	0.000157	0.00053	CcSEcCtD
Meloxicam—Headache—Bimatoprost—glaucoma	0.000157	0.00053	CcSEcCtD
Meloxicam—Nervous system disorder—Clonidine—glaucoma	0.000156	0.000529	CcSEcCtD
Meloxicam—Thrombocytopenia—Clonidine—glaucoma	0.000156	0.000529	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000156	0.00381	CbGpPWpGaD
Meloxicam—Hypersensitivity—Dorzolamide—glaucoma	0.000156	0.000527	CcSEcCtD
Meloxicam—Tachycardia—Clonidine—glaucoma	0.000156	0.000527	CcSEcCtD
Meloxicam—Hypersensitivity—Travoprost—glaucoma	0.000155	0.000525	CcSEcCtD
Meloxicam—Skin disorder—Clonidine—glaucoma	0.000155	0.000524	CcSEcCtD
Meloxicam—Hyperhidrosis—Clonidine—glaucoma	0.000154	0.000522	CcSEcCtD
Meloxicam—Visual impairment—Timolol—glaucoma	0.000154	0.000521	CcSEcCtD
Meloxicam—Malaise—Betaxolol—glaucoma	0.000153	0.000519	CcSEcCtD
Meloxicam—Nausea—Apraclonidine—glaucoma	0.000153	0.000518	CcSEcCtD
Meloxicam—Hypersensitivity—Brinzolamide—glaucoma	0.000153	0.000518	CcSEcCtD
Meloxicam—Vertigo—Betaxolol—glaucoma	0.000153	0.000517	CcSEcCtD
Meloxicam—Syncope—Betaxolol—glaucoma	0.000153	0.000517	CcSEcCtD
Meloxicam—Dizziness—Acetazolamide—glaucoma	0.000152	0.000516	CcSEcCtD
Meloxicam—Asthenia—Dorzolamide—glaucoma	0.000152	0.000513	CcSEcCtD
Meloxicam—Asthenia—Travoprost—glaucoma	0.000151	0.000511	CcSEcCtD
Meloxicam—Palpitations—Betaxolol—glaucoma	0.00015	0.000509	CcSEcCtD
Meloxicam—Pruritus—Dorzolamide—glaucoma	0.00015	0.000506	CcSEcCtD
Meloxicam—Loss of consciousness—Betaxolol—glaucoma	0.00015	0.000506	CcSEcCtD
Meloxicam—Eye disorder—Timolol—glaucoma	0.000149	0.000505	CcSEcCtD
Meloxicam—Asthenia—Brinzolamide—glaucoma	0.000149	0.000505	CcSEcCtD
Meloxicam—Hypotension—Clonidine—glaucoma	0.000149	0.000505	CcSEcCtD
Meloxicam—Pruritus—Travoprost—glaucoma	0.000149	0.000504	CcSEcCtD
Meloxicam—Tinnitus—Timolol—glaucoma	0.000149	0.000504	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—GSTM1—glaucoma	0.000149	0.00363	CbGpPWpGaD
Meloxicam—Cough—Betaxolol—glaucoma	0.000148	0.000503	CcSEcCtD
Meloxicam—Nausea—Bimatoprost—glaucoma	0.000148	0.000503	CcSEcCtD
Meloxicam—Cardiac disorder—Timolol—glaucoma	0.000148	0.000502	CcSEcCtD
Meloxicam—Hypersensitivity—Pilocarpine—glaucoma	0.000147	0.000498	CcSEcCtD
Meloxicam—Pruritus—Brinzolamide—glaucoma	0.000147	0.000498	CcSEcCtD
Meloxicam—Vomiting—Acetazolamide—glaucoma	0.000147	0.000496	CcSEcCtD
Meloxicam—Dizziness—Brimonidine—glaucoma	0.000146	0.000495	CcSEcCtD
Meloxicam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000146	0.00356	CbGpPWpGaD
Meloxicam—Musculoskeletal discomfort—Clonidine—glaucoma	0.000145	0.000492	CcSEcCtD
Meloxicam—Angiopathy—Timolol—glaucoma	0.000145	0.00049	CcSEcCtD
Meloxicam—Myalgia—Betaxolol—glaucoma	0.000145	0.00049	CcSEcCtD
Meloxicam—Arthralgia—Betaxolol—glaucoma	0.000145	0.00049	CcSEcCtD
Meloxicam—Diarrhoea—Dorzolamide—glaucoma	0.000145	0.00049	CcSEcCtD
Meloxicam—Headache—Acetazolamide—glaucoma	0.000144	0.000489	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000144	0.00352	CbGpPWpGaD
Meloxicam—Anxiety—Betaxolol—glaucoma	0.000144	0.000489	CcSEcCtD
Meloxicam—Insomnia—Clonidine—glaucoma	0.000144	0.000488	CcSEcCtD
Meloxicam—Immune system disorder—Timolol—glaucoma	0.000144	0.000488	CcSEcCtD
Meloxicam—Diarrhoea—Travoprost—glaucoma	0.000144	0.000487	CcSEcCtD
Meloxicam—Mediastinal disorder—Timolol—glaucoma	0.000144	0.000487	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000144	0.000487	CcSEcCtD
Meloxicam—Asthenia—Pilocarpine—glaucoma	0.000143	0.000485	CcSEcCtD
Meloxicam—Paraesthesia—Clonidine—glaucoma	0.000143	0.000485	CcSEcCtD
Meloxicam—Discomfort—Betaxolol—glaucoma	0.000143	0.000484	CcSEcCtD
Meloxicam—Arrhythmia—Timolol—glaucoma	0.000143	0.000483	CcSEcCtD
Meloxicam—Dyspnoea—Clonidine—glaucoma	0.000142	0.000481	CcSEcCtD
Meloxicam—Diarrhoea—Brinzolamide—glaucoma	0.000142	0.000481	CcSEcCtD
Meloxicam—Somnolence—Clonidine—glaucoma	0.000142	0.00048	CcSEcCtD
Meloxicam—Dry mouth—Betaxolol—glaucoma	0.000142	0.00048	CcSEcCtD
Meloxicam—Pruritus—Pilocarpine—glaucoma	0.000141	0.000478	CcSEcCtD
Meloxicam—Alopecia—Timolol—glaucoma	0.000141	0.000478	CcSEcCtD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00014	0.00342	CbGpPWpGaD
Meloxicam—Confusional state—Betaxolol—glaucoma	0.00014	0.000474	CcSEcCtD
Meloxicam—Mental disorder—Timolol—glaucoma	0.00014	0.000474	CcSEcCtD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00014	0.00341	CbGpPWpGaD
Meloxicam—Dizziness—Dorzolamide—glaucoma	0.00014	0.000473	CcSEcCtD
Meloxicam—Rash—Brimonidine—glaucoma	0.00014	0.000472	CcSEcCtD
Meloxicam—Dermatitis—Brimonidine—glaucoma	0.000139	0.000472	CcSEcCtD
Meloxicam—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000139	0.0034	CbGpPWpGaD
Meloxicam—Dizziness—Travoprost—glaucoma	0.000139	0.000471	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000139	0.00339	CbGpPWpGaD
Meloxicam—Malnutrition—Timolol—glaucoma	0.000139	0.000471	CcSEcCtD
Meloxicam—Erythema—Timolol—glaucoma	0.000139	0.000471	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000139	0.00339	CbGpPWpGaD
Meloxicam—Oedema—Betaxolol—glaucoma	0.000139	0.00047	CcSEcCtD
Meloxicam—Headache—Brimonidine—glaucoma	0.000139	0.000469	CcSEcCtD
Meloxicam—Decreased appetite—Clonidine—glaucoma	0.000139	0.000469	CcSEcCtD
Meloxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000139	0.00338	CbGpPWpGaD
Meloxicam—Infection—Betaxolol—glaucoma	0.000138	0.000467	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Clonidine—glaucoma	0.000138	0.000466	CcSEcCtD
Meloxicam—Fatigue—Clonidine—glaucoma	0.000137	0.000465	CcSEcCtD
Meloxicam—Dizziness—Brinzolamide—glaucoma	0.000137	0.000465	CcSEcCtD
Meloxicam—Nausea—Acetazolamide—glaucoma	0.000137	0.000464	CcSEcCtD
Meloxicam—Diarrhoea—Pilocarpine—glaucoma	0.000137	0.000463	CcSEcCtD
Meloxicam—Shock—Betaxolol—glaucoma	0.000137	0.000462	CcSEcCtD
Meloxicam—Tension—Timolol—glaucoma	0.000136	0.000462	CcSEcCtD
Meloxicam—Constipation—Clonidine—glaucoma	0.000136	0.000462	CcSEcCtD
Meloxicam—Pain—Clonidine—glaucoma	0.000136	0.000462	CcSEcCtD
Meloxicam—Nervous system disorder—Betaxolol—glaucoma	0.000136	0.000461	CcSEcCtD
Meloxicam—Dysgeusia—Timolol—glaucoma	0.000136	0.000461	CcSEcCtD
Meloxicam—Thrombocytopenia—Betaxolol—glaucoma	0.000136	0.00046	CcSEcCtD
Meloxicam—Tachycardia—Betaxolol—glaucoma	0.000135	0.000459	CcSEcCtD
Meloxicam—Nervousness—Timolol—glaucoma	0.000135	0.000457	CcSEcCtD
Meloxicam—Skin disorder—Betaxolol—glaucoma	0.000135	0.000457	CcSEcCtD
Meloxicam—Vomiting—Dorzolamide—glaucoma	0.000134	0.000455	CcSEcCtD
Meloxicam—Hyperhidrosis—Betaxolol—glaucoma	0.000134	0.000454	CcSEcCtD
Meloxicam—Rash—Dorzolamide—glaucoma	0.000133	0.000451	CcSEcCtD
Meloxicam—Dermatitis—Dorzolamide—glaucoma	0.000133	0.000451	CcSEcCtD
Meloxicam—Rash—Travoprost—glaucoma	0.000133	0.000449	CcSEcCtD
Meloxicam—Dermatitis—Travoprost—glaucoma	0.000133	0.000449	CcSEcCtD
Meloxicam—Headache—Dorzolamide—glaucoma	0.000132	0.000448	CcSEcCtD
Meloxicam—Vomiting—Brinzolamide—glaucoma	0.000132	0.000447	CcSEcCtD
Meloxicam—Dizziness—Pilocarpine—glaucoma	0.000132	0.000447	CcSEcCtD
Meloxicam—Headache—Travoprost—glaucoma	0.000132	0.000446	CcSEcCtD
Meloxicam—Nausea—Brimonidine—glaucoma	0.000131	0.000445	CcSEcCtD
Meloxicam—Feeling abnormal—Clonidine—glaucoma	0.000131	0.000445	CcSEcCtD
Meloxicam—PGD—Disease—HDAC9—glaucoma	0.000131	0.0032	CbGpPWpGaD
Meloxicam—Rash—Brinzolamide—glaucoma	0.000131	0.000444	CcSEcCtD
Meloxicam—Vision blurred—Timolol—glaucoma	0.000131	0.000443	CcSEcCtD
Meloxicam—Dermatitis—Brinzolamide—glaucoma	0.000131	0.000443	CcSEcCtD
Meloxicam—Gastrointestinal pain—Clonidine—glaucoma	0.00013	0.000442	CcSEcCtD
Meloxicam—Headache—Brinzolamide—glaucoma	0.00013	0.000441	CcSEcCtD
Meloxicam—Hypotension—Betaxolol—glaucoma	0.00013	0.000439	CcSEcCtD
Meloxicam—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000129	0.00316	CbGpPWpGaD
Meloxicam—Angioedema—Timolol—glaucoma	0.000127	0.00043	CcSEcCtD
Meloxicam—Vomiting—Pilocarpine—glaucoma	0.000127	0.00043	CcSEcCtD
Meloxicam—Urticaria—Clonidine—glaucoma	0.000127	0.000429	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000126	0.000428	CcSEcCtD
Meloxicam—Body temperature increased—Clonidine—glaucoma	0.000126	0.000427	CcSEcCtD
Meloxicam—Abdominal pain—Clonidine—glaucoma	0.000126	0.000427	CcSEcCtD
Meloxicam—Rash—Pilocarpine—glaucoma	0.000126	0.000426	CcSEcCtD
Meloxicam—Dermatitis—Pilocarpine—glaucoma	0.000126	0.000426	CcSEcCtD
Meloxicam—Insomnia—Betaxolol—glaucoma	0.000126	0.000425	CcSEcCtD
Meloxicam—Nausea—Dorzolamide—glaucoma	0.000126	0.000425	CcSEcCtD
Meloxicam—Headache—Pilocarpine—glaucoma	0.000125	0.000424	CcSEcCtD
Meloxicam—Nausea—Travoprost—glaucoma	0.000125	0.000423	CcSEcCtD
Meloxicam—Vertigo—Timolol—glaucoma	0.000125	0.000423	CcSEcCtD
Meloxicam—Paraesthesia—Betaxolol—glaucoma	0.000125	0.000422	CcSEcCtD
Meloxicam—Syncope—Timolol—glaucoma	0.000125	0.000422	CcSEcCtD
Meloxicam—Dyspnoea—Betaxolol—glaucoma	0.000124	0.000419	CcSEcCtD
Meloxicam—Nausea—Brinzolamide—glaucoma	0.000123	0.000418	CcSEcCtD
Meloxicam—Palpitations—Timolol—glaucoma	0.000123	0.000416	CcSEcCtD
Meloxicam—Dyspepsia—Betaxolol—glaucoma	0.000122	0.000414	CcSEcCtD
Meloxicam—Loss of consciousness—Timolol—glaucoma	0.000122	0.000414	CcSEcCtD
Meloxicam—Cough—Timolol—glaucoma	0.000121	0.000411	CcSEcCtD
Meloxicam—Decreased appetite—Betaxolol—glaucoma	0.000121	0.000409	CcSEcCtD
Meloxicam—Hypertension—Timolol—glaucoma	0.00012	0.000406	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Betaxolol—glaucoma	0.00012	0.000406	CcSEcCtD
Meloxicam—Fatigue—Betaxolol—glaucoma	0.00012	0.000405	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000119	0.0029	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.000119	0.0029	CbGpPWpGaD
Meloxicam—Constipation—Betaxolol—glaucoma	0.000119	0.000402	CcSEcCtD
Meloxicam—Pain—Betaxolol—glaucoma	0.000119	0.000402	CcSEcCtD
Meloxicam—Nausea—Pilocarpine—glaucoma	0.000119	0.000402	CcSEcCtD
Meloxicam—Arthralgia—Timolol—glaucoma	0.000118	0.000401	CcSEcCtD
Meloxicam—Myalgia—Timolol—glaucoma	0.000118	0.000401	CcSEcCtD
Meloxicam—Anxiety—Timolol—glaucoma	0.000118	0.000399	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000117	0.000398	CcSEcCtD
Meloxicam—Hypersensitivity—Clonidine—glaucoma	0.000117	0.000398	CcSEcCtD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000117	0.00286	CbGpPWpGaD
Meloxicam—Discomfort—Timolol—glaucoma	0.000117	0.000396	CcSEcCtD
Meloxicam—Dry mouth—Timolol—glaucoma	0.000116	0.000392	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.000115	0.0028	CbGpPWpGaD
Meloxicam—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000115	0.00279	CbGpPWpGaD
Meloxicam—Asthenia—Clonidine—glaucoma	0.000114	0.000387	CcSEcCtD
Meloxicam—Feeling abnormal—Betaxolol—glaucoma	0.000114	0.000387	CcSEcCtD
Meloxicam—Confusional state—Timolol—glaucoma	0.000114	0.000387	CcSEcCtD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000114	0.00278	CbGpPWpGaD
Meloxicam—PGD—Metabolism—TXN—glaucoma	0.000113	0.00277	CbGpPWpGaD
Meloxicam—Anaphylactic shock—Timolol—glaucoma	0.000113	0.000384	CcSEcCtD
Meloxicam—Oedema—Timolol—glaucoma	0.000113	0.000384	CcSEcCtD
Meloxicam—Pruritus—Clonidine—glaucoma	0.000113	0.000382	CcSEcCtD
Meloxicam—Infection—Timolol—glaucoma	0.000113	0.000381	CcSEcCtD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000112	0.00273	CbGpPWpGaD
Meloxicam—Shock—Timolol—glaucoma	0.000112	0.000378	CcSEcCtD
Meloxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000111	0.00271	CbGpPWpGaD
Meloxicam—Nervous system disorder—Timolol—glaucoma	0.000111	0.000377	CcSEcCtD
Meloxicam—Urticaria—Betaxolol—glaucoma	0.00011	0.000373	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.00011	0.00269	CbGpPWpGaD
Meloxicam—Skin disorder—Timolol—glaucoma	0.00011	0.000373	CcSEcCtD
Meloxicam—Body temperature increased—Betaxolol—glaucoma	0.00011	0.000372	CcSEcCtD
Meloxicam—Hyperhidrosis—Timolol—glaucoma	0.00011	0.000371	CcSEcCtD
Meloxicam—Diarrhoea—Clonidine—glaucoma	0.000109	0.000369	CcSEcCtD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000107	0.00262	CbGpPWpGaD
Meloxicam—ABCC4—Platelet degranulation—VEGFA—glaucoma	0.000107	0.00261	CbGpPWpGaD
Meloxicam—Hypotension—Timolol—glaucoma	0.000106	0.000359	CcSEcCtD
Meloxicam—Dizziness—Clonidine—glaucoma	0.000105	0.000357	CcSEcCtD
Meloxicam—PTGS2—Spinal Cord Injury—BDNF—glaucoma	0.000103	0.00252	CbGpPWpGaD
Meloxicam—Musculoskeletal discomfort—Timolol—glaucoma	0.000103	0.00035	CcSEcCtD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000103	0.00251	CbGpPWpGaD
Meloxicam—Insomnia—Timolol—glaucoma	0.000103	0.000347	CcSEcCtD
Meloxicam—Hypersensitivity—Betaxolol—glaucoma	0.000102	0.000346	CcSEcCtD
Meloxicam—Paraesthesia—Timolol—glaucoma	0.000102	0.000345	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.000102	0.00248	CbGpPWpGaD
Meloxicam—Vomiting—Clonidine—glaucoma	0.000101	0.000343	CcSEcCtD
Meloxicam—PTGS1—Metabolism—CA5A—glaucoma	0.000101	0.00247	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NARFL—glaucoma	0.000101	0.00247	CbGpPWpGaD
Meloxicam—Dyspnoea—Timolol—glaucoma	0.000101	0.000342	CcSEcCtD
Meloxicam—Somnolence—Timolol—glaucoma	0.000101	0.000341	CcSEcCtD
Meloxicam—Rash—Clonidine—glaucoma	0.000101	0.00034	CcSEcCtD
Meloxicam—Dermatitis—Clonidine—glaucoma	0.0001	0.00034	CcSEcCtD
Meloxicam—Headache—Clonidine—glaucoma	9.99e-05	0.000338	CcSEcCtD
Meloxicam—Dyspepsia—Timolol—glaucoma	9.98e-05	0.000338	CcSEcCtD
Meloxicam—Asthenia—Betaxolol—glaucoma	9.96e-05	0.000337	CcSEcCtD
Meloxicam—PTGS2—Spinal Cord Injury—IL1A—glaucoma	9.92e-05	0.00242	CbGpPWpGaD
Meloxicam—Decreased appetite—Timolol—glaucoma	9.86e-05	0.000334	CcSEcCtD
Meloxicam—Pruritus—Betaxolol—glaucoma	9.82e-05	0.000333	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Timolol—glaucoma	9.79e-05	0.000332	CcSEcCtD
Meloxicam—Fatigue—Timolol—glaucoma	9.78e-05	0.000331	CcSEcCtD
Meloxicam—Pain—Timolol—glaucoma	9.7e-05	0.000328	CcSEcCtD
Meloxicam—Diarrhoea—Betaxolol—glaucoma	9.5e-05	0.000322	CcSEcCtD
Meloxicam—Nausea—Clonidine—glaucoma	9.47e-05	0.000321	CcSEcCtD
Meloxicam—Feeling abnormal—Timolol—glaucoma	9.35e-05	0.000316	CcSEcCtD
Meloxicam—CYP2C8—Biological oxidations—GSTT1—glaucoma	9.32e-05	0.00227	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	9.31e-05	0.00227	CbGpPWpGaD
Meloxicam—Gastrointestinal pain—Timolol—glaucoma	9.27e-05	0.000314	CcSEcCtD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.26e-05	0.00226	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—GSTM1—glaucoma	9.19e-05	0.00224	CbGpPWpGaD
Meloxicam—Dizziness—Betaxolol—glaucoma	9.18e-05	0.000311	CcSEcCtD
Meloxicam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.14e-05	0.00223	CbGpPWpGaD
Meloxicam—Urticaria—Timolol—glaucoma	9.01e-05	0.000305	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	9e-05	0.00219	CbGpPWpGaD
Meloxicam—Body temperature increased—Timolol—glaucoma	8.97e-05	0.000304	CcSEcCtD
Meloxicam—Abdominal pain—Timolol—glaucoma	8.97e-05	0.000304	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	8.86e-05	0.00216	CbGpPWpGaD
Meloxicam—Vomiting—Betaxolol—glaucoma	8.83e-05	0.000299	CcSEcCtD
Meloxicam—PGD—Metabolism—GSTT1—glaucoma	8.8e-05	0.00215	CbGpPWpGaD
Meloxicam—Rash—Betaxolol—glaucoma	8.75e-05	0.000296	CcSEcCtD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	8.75e-05	0.00213	CbGpPWpGaD
Meloxicam—Dermatitis—Betaxolol—glaucoma	8.75e-05	0.000296	CcSEcCtD
Meloxicam—Headache—Betaxolol—glaucoma	8.7e-05	0.000294	CcSEcCtD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.6e-05	0.0021	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.53e-05	0.00208	CbGpPWpGaD
Meloxicam—Hypersensitivity—Timolol—glaucoma	8.36e-05	0.000283	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—FN1—glaucoma	8.28e-05	0.00202	CbGpPWpGaD
Meloxicam—Nausea—Betaxolol—glaucoma	8.25e-05	0.000279	CcSEcCtD
Meloxicam—Asthenia—Timolol—glaucoma	8.14e-05	0.000276	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—TGFB2—glaucoma	8.1e-05	0.00197	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CA5A—glaucoma	8.03e-05	0.00196	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NARFL—glaucoma	8.03e-05	0.00196	CbGpPWpGaD
Meloxicam—Pruritus—Timolol—glaucoma	8.02e-05	0.000272	CcSEcCtD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	7.98e-05	0.00195	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	7.81e-05	0.0019	CbGpPWpGaD
Meloxicam—Diarrhoea—Timolol—glaucoma	7.76e-05	0.000263	CcSEcCtD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	7.68e-05	0.00187	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GSTT1—glaucoma	7.59e-05	0.00185	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.51e-05	0.00183	CbGpPWpGaD
Meloxicam—Dizziness—Timolol—glaucoma	7.5e-05	0.000254	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	7.46e-05	0.00182	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—CYP1B1—glaucoma	7.43e-05	0.00181	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	7.33e-05	0.00179	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	7.32e-05	0.00179	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LRP12—glaucoma	7.27e-05	0.00177	CbGpPWpGaD
Meloxicam—Vomiting—Timolol—glaucoma	7.21e-05	0.000244	CcSEcCtD
Meloxicam—Rash—Timolol—glaucoma	7.15e-05	0.000242	CcSEcCtD
Meloxicam—Dermatitis—Timolol—glaucoma	7.14e-05	0.000242	CcSEcCtD
Meloxicam—Headache—Timolol—glaucoma	7.11e-05	0.000241	CcSEcCtD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.08e-05	0.00173	CbGpPWpGaD
Meloxicam—PGD—Disease—CDKN2B—glaucoma	7.06e-05	0.00172	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.03e-05	0.00171	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CYP1B1—glaucoma	7.01e-05	0.00171	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ABCA1—glaucoma	7.01e-05	0.00171	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.94e-05	0.00169	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	6.91e-05	0.00169	CbGpPWpGaD
Meloxicam—Nausea—Timolol—glaucoma	6.74e-05	0.000228	CcSEcCtD
Meloxicam—CYP2C8—Metabolism—NARFL—glaucoma	6.53e-05	0.00159	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA5A—glaucoma	6.53e-05	0.00159	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SOD1—glaucoma	6.14e-05	0.0015	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—CYP1B1—glaucoma	6.05e-05	0.00147	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.02e-05	0.00147	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	5.98e-05	0.00146	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	5.96e-05	0.00145	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—GSTM1—glaucoma	5.94e-05	0.00145	CbGpPWpGaD
Meloxicam—PGD—Disease—MTHFR—glaucoma	5.92e-05	0.00144	CbGpPWpGaD
Meloxicam—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	5.86e-05	0.00143	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.65e-05	0.00138	CbGpPWpGaD
Meloxicam—PGD—Metabolism—GSTM1—glaucoma	5.61e-05	0.00137	CbGpPWpGaD
Meloxicam—PGD—Disease—APOE—glaucoma	5.51e-05	0.00134	CbGpPWpGaD
Meloxicam—PGD—Disease—CAV1—glaucoma	5.46e-05	0.00133	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA5A—glaucoma	5.32e-05	0.0013	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NARFL—glaucoma	5.32e-05	0.0013	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	5.27e-05	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.15e-05	0.00125	CbGpPWpGaD
Meloxicam—PGD—Disease—BAD—glaucoma	5.13e-05	0.00125	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTT1—glaucoma	5e-05	0.00122	CbGpPWpGaD
Meloxicam—PGD—Metabolism—MTHFR—glaucoma	4.95e-05	0.00121	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CA1—glaucoma	4.94e-05	0.0012	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—glaucoma	4.88e-05	0.00119	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—GSTM1—glaucoma	4.83e-05	0.00118	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CTSA—glaucoma	4.78e-05	0.00117	CbGpPWpGaD
Meloxicam—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	4.77e-05	0.00116	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	4.75e-05	0.00116	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—glaucoma	4.74e-05	0.00116	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FGFR1OP—glaucoma	4.68e-05	0.00114	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HEYL—glaucoma	4.68e-05	0.00114	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MMP1—glaucoma	4.68e-05	0.00114	CbGpPWpGaD
Meloxicam—PGD—Metabolism—APOE—glaucoma	4.61e-05	0.00112	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CAV1—glaucoma	4.57e-05	0.00111	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CA2—glaucoma	4.52e-05	0.0011	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CAV1—glaucoma	4.49e-05	0.00109	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.42e-05	0.00108	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.42e-05	0.00108	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—FN1—glaucoma	4.27e-05	0.00104	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS3—glaucoma	4.13e-05	0.00101	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.99e-05	0.000972	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.93e-05	0.000959	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CA1—glaucoma	3.92e-05	0.000956	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CTSA—glaucoma	3.8e-05	0.000926	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—glaucoma	3.77e-05	0.00092	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—glaucoma	3.75e-05	0.000916	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CA2—glaucoma	3.59e-05	0.000875	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.58e-05	0.000874	CbGpPWpGaD
Meloxicam—PGD—Disease—CDKN1B—glaucoma	3.57e-05	0.000871	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NARFL—glaucoma	3.51e-05	0.000855	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA5A—glaucoma	3.51e-05	0.000855	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.51e-05	0.000855	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.51e-05	0.000855	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NOS3—glaucoma	3.46e-05	0.000842	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NOS3—glaucoma	3.39e-05	0.000827	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—glaucoma	3.31e-05	0.000807	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA1—glaucoma	3.19e-05	0.000778	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.19e-05	0.000777	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TXN—glaucoma	3.18e-05	0.000776	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—glaucoma	3.16e-05	0.000771	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.14e-05	0.000767	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CTSA—glaucoma	3.09e-05	0.000754	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.98e-05	0.000727	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HDAC9—glaucoma	2.92e-05	0.000713	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA2—glaucoma	2.92e-05	0.000712	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.9e-05	0.000708	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.88e-05	0.000702	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.85e-05	0.000696	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.85e-05	0.000696	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA1—glaucoma	2.6e-05	0.000633	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.55e-05	0.000623	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TXN—glaucoma	2.53e-05	0.000616	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CTSA—glaucoma	2.52e-05	0.000613	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTT1—glaucoma	2.47e-05	0.000602	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—glaucoma	2.44e-05	0.000596	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA2—glaucoma	2.38e-05	0.000579	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.32e-05	0.000566	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.32e-05	0.000566	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.31e-05	0.000562	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.28e-05	0.000557	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.25e-05	0.000549	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TXN—glaucoma	2.06e-05	0.000501	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.99e-05	0.000485	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1B1—glaucoma	1.97e-05	0.00048	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCA1—glaucoma	1.97e-05	0.00048	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTT1—glaucoma	1.96e-05	0.000478	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.88e-05	0.000457	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.86e-05	0.000453	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—glaucoma	1.85e-05	0.00045	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA1—glaucoma	1.71e-05	0.000418	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TXN—glaucoma	1.67e-05	0.000408	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CTSA—glaucoma	1.66e-05	0.000404	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTT1—glaucoma	1.59e-05	0.000389	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—glaucoma	1.57e-05	0.000383	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN2B—glaucoma	1.57e-05	0.000383	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA2—glaucoma	1.57e-05	0.000382	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1B1—glaucoma	1.56e-05	0.000381	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCA1—glaucoma	1.56e-05	0.000381	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.53e-05	0.000372	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.51e-05	0.000369	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MTHFR—glaucoma	1.39e-05	0.000339	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTHFR—glaucoma	1.32e-05	0.000321	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTT1—glaucoma	1.3e-05	0.000316	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOE—glaucoma	1.29e-05	0.000315	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.29e-05	0.000313	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAV1—glaucoma	1.28e-05	0.000313	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCA1—glaucoma	1.27e-05	0.00031	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1B1—glaucoma	1.27e-05	0.00031	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—glaucoma	1.25e-05	0.000304	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOE—glaucoma	1.23e-05	0.000299	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CAV1—glaucoma	1.21e-05	0.000296	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BAD—glaucoma	1.14e-05	0.000279	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TXN—glaucoma	1.1e-05	0.000269	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MTHFR—glaucoma	1.1e-05	0.000269	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.05e-05	0.000255	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1B1—glaucoma	1.03e-05	0.000252	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCA1—glaucoma	1.03e-05	0.000252	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOE—glaucoma	1.03e-05	0.00025	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAV1—glaucoma	1.02e-05	0.000248	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—glaucoma	1.02e-05	0.000248	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—glaucoma	9.69e-06	0.000236	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—glaucoma	9.19e-06	0.000224	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MTHFR—glaucoma	8.98e-06	0.000219	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—glaucoma	8.86e-06	0.000216	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTT1—glaucoma	8.56e-06	0.000209	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOE—glaucoma	8.36e-06	0.000204	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAV1—glaucoma	8.28e-06	0.000202	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—glaucoma	8.27e-06	0.000202	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1B—glaucoma	7.96e-06	0.000194	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—glaucoma	7.69e-06	0.000188	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTHFR—glaucoma	7.3e-06	0.000178	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCA1—glaucoma	6.82e-06	0.000166	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1B1—glaucoma	6.82e-06	0.000166	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOE—glaucoma	6.8e-06	0.000166	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAV1—glaucoma	6.74e-06	0.000164	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—glaucoma	6.26e-06	0.000153	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—glaucoma	5.73e-06	0.00014	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—glaucoma	5.45e-06	0.000133	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—glaucoma	5.09e-06	0.000124	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTHFR—glaucoma	4.82e-06	0.000117	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—glaucoma	4.66e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOE—glaucoma	4.48e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAV1—glaucoma	4.44e-06	0.000108	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—glaucoma	3.36e-06	8.19e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—glaucoma	3.07e-06	7.49e-05	CbGpPWpGaD
